Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
Sarah A. Best(Walter and Eliza Hall Institute of Medical Research), Ana Janic(Universitat Pompeu Fabra)
Cited by 18
Related Papers
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
|Nature Communications|2019|109
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains
|Neuro-Oncology Advances|2023|52
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability
|Journal of Experimental & Clinical Cancer Research|2024|12
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains
|bioRxiv (Cold Spring Harbor Laboratory)|2023|11